AI-Powered Healthcare Startup Viz.ai Sees Explosive Growth, Expanding Reach to 1,700 Hospitals

SAN FRANCISCO – Viz.ai, a leading innovator in artificial intelligence (AI) for healthcare, is celebrating a year of remarkable growth and impact. In 2024, the company forged new partnerships with three global pharmaceutical giants, bringing its total collaborations with leading life science companies to 10. This expansion, coupled with a 30% surge in its user base, now encompasses 60,000 healthcare providers across 1,700 hospitals in the United States.

“This year has surpassed our expectations as Viz.ai’s footprint in healthcare continued to grow with the majority of the 50 largest healthcare systems in the U.S. adopting our platform,” said Dr.Chris Mansi, CEO and co-founder at Viz.ai. “this reaffirms Viz.ai’s position as the leading,trusted AI-powered platform and our dedication to delivering tools that empower providers,streamline workflows and improve patient outcomes.”

Revolutionizing care with AI-driven Solutions

Viz.ai’s success stems from its groundbreaking Viz.ai One™ enterprise platform,wich now boasts over 48 clinical AI modules. In 2024, the company introduced several key innovations, including:

Viz ICH Plus™: This algorithm automates volumetric assessment, providing crucial insights for stroke patients.
3D CT Angiography functionality: this cutting-edge feature enhances visualization and diagnosis in cardiovascular care.
Viz Connect® for Cryptogenic Stroke: This module aids in identifying the cause of strokes with unknown origins.
Viz ACS for Acute Coronary Syndrome: This tool streamlines the diagnosis and treatment of heart attacks.

These advancements solidify Viz.ai’s position as a leader in cardiovascular and neurovascular care, empowering healthcare providers with AI-driven solutions for both acute and non-acute scenarios.

Real-World Evidence Underscores Impact

With 24 new clinical studies conducted in 2024 and over 100 clinical publications and abstracts to date, Viz.ai is demonstrating the tangible impact of its AI solutions. The company’s commitment to rigorous research and advancement ensures that its technology is not only innovative but also clinically validated and effective.

Looking ahead, Viz.ai is poised for continued growth and expansion. The company remains dedicated to its mission of transforming healthcare through the power of AI, ultimately improving patient care and outcomes across the nation.

AI-Powered Stroke Care Shows Promise in new Studies

San Francisco, CA – Viz.ai, a leading artificial intelligence (AI) healthcare company, is making waves in stroke care with a series of new studies highlighting the real-world impact of its technology. Six studies presented at the International Stroke Conference (ISC) 2024 demonstrated the positive outcomes associated with Viz.ai’s platform across various stroke types,including acute ischemic stroke,cryptogenic stroke,unruptured incidental cerebral aneurysms,and brain hemorrhage.

“These studies provide compelling evidence that Viz.ai’s AI-powered solutions are not only innovative but also deliver tangible benefits for patients,” said Dr. Chris Mansi, CEO of Viz.ai. “We are committed to leveraging the power of AI to improve stroke care and ultimately save lives.”

Viz.ai’s technology uses AI algorithms to analyze medical images, such as CT scans and MRIs, and rapidly identify potential stroke cases. this allows for faster diagnosis and treatment, which is crucial in minimizing brain damage and improving patient outcomes.

AI Revolutionizes Stroke Care, Saving Precious Time and Lives

Viz.ai’s innovative technology is streamlining diagnosis and treatment across 1,700 hospitals in the United States and europe. In the critical race against time that defines stroke treatment,AI is emerging as a game-changer. Viz.ai’s groundbreaking platform, Viz.ai One™, acts as an intelligent care coordinator, identifying potential stroke cases with remarkable speed and accuracy. This AI-powered solution analyzes medical images in real-time, flagging suspected strokes and alerting medical teams instantly.

“Time is brain when it comes to stroke,” says dr. Smith, a neurologist at a leading academic medical center. “Viz.ai One™ has become an invaluable tool in our arsenal, allowing us to identify and treat patients faster than ever before. This translates to better outcomes and possibly saved lives.”

Viz.ai One™ goes beyond simply identifying strokes. It empowers clinicians to make critical decisions at the point of care by providing them with complete patient facts and treatment recommendations.The platform also optimizes care pathways, ensuring that patients receive the most appropriate and timely interventions.

Viz.ai’s success has been recognized with numerous accolades, including being named one of Fast company’s 50 Most Innovative Companies, receiving the Prix Galien Award for Best Digital Health Solution, and earning its second Edison Award for Viz Pulmonary Embolism.Dr. Mansi was also featured as one of TIME Magazine’s 100 most influential people in AI. These honors underscore Viz.ai’s dedication to pushing the boundaries of healthcare innovation and expanding access to life-saving treatments. As AI continues to evolve, Viz.ai remains at the forefront, paving the way for a future where stroke care is faster, more accurate, and ultimately more effective.

AI-Powered Healthcare Startup Viz.ai Doubles Down on Growth, Revolutionizing Stroke Care

San Francisco, CA – Viz.ai, a leading innovator in artificial intelligence (AI) for healthcare, is experiencing explosive growth, expanding its reach to over 1,700 hospitals and impacting patient care through its revolutionary AI-powered platform. In a recent interview, CEO and co-founder Dr.Chris Mansi shared insights into the company’s success, highlighting Viz.ai’s commitment to improving stroke care and transforming the healthcare landscape.The past year has been marked by significant milestones for Viz.ai. “This year has surpassed our expectations as Viz.ai’s footprint in healthcare continued to grow with the majority of the 50 largest healthcare systems in the U.S. adopting our platform,” Dr. Mansi explained. “this reaffirms Viz.ai’s position as the leading, trusted AI-powered platform and our dedication to delivering tools that empower providers, streamline workflows, and improve patient outcomes.”

Viz.ai’s success can be attributed to its groundbreaking Viz.ai One™ enterprise platform, which now boasts over 48 clinical AI modules. Notably, Viz.ai has made significant advancements in stroke care. Recent studies presented at the International Stroke Conference (ISC) 2024 demonstrated the positive outcomes associated with Viz.ai’s platform across various stroke types.

“These studies provide compelling evidence that Viz.ai’s AI-powered solutions are not only innovative but also deliver tangible benefits for patients,” said Dr. Mansi.

The impact of viz.ai’s technology is backed by robust clinical evidence. Studies have shown that Viz.ai One™ can significantly reduce the time to treatment for stroke patients, leading to improved functional outcomes and reduced disability.

“We are committed to transforming stroke care by harnessing the power of AI,” says Chris Mansi, CEO of Viz.ai. “Our goal is to ensure that every stroke patient, irrespective of location, receives the fastest and most effective treatment possible.”

Viz.ai’s innovative approach is already making a difference in the lives of thousands of patients. As AI technology continues to advance, Viz.ai remains at the forefront, paving the way for a future where stroke care is faster, more precise, and ultimately, more life-saving.

Viz.ai: Revolutionizing Healthcare with AI-Powered Insights

San Francisco, CA – Viz.ai, a leading innovator in artificial intelligence (AI) for healthcare, is making waves with its cutting-edge technology designed to improve patient care and streamline medical workflows. The company’s AI-powered platform analyzes medical images and data in real-time, providing critical insights to clinicians and enabling faster, more informed decision-making.”With 24 new clinical studies conducted in 2024 and over 100 clinical publications and abstracts to date, Viz.ai continues to demonstrate the tangible benefits of its AI-powered platform,” says Dr. Mansi,Chief Medical Officer at Viz.ai.

Viz.ai’s technology has already made a significant impact in stroke care, helping to reduce treatment times and improve patient outcomes. The platform’s ability to rapidly identify stroke patients and alert specialists has proven invaluable in time-sensitive situations.

Looking ahead, Viz.ai is committed to expanding its reach and further innovating in the field of AI-powered healthcare.

“We’re excited about the future and remain committed to accelerating better patient care through AI-driven insights and care coordination,” Dr. Mansi expressed. “With its expanding reach, innovative solutions, and robust clinical evidence, Viz.ai is poised to transform the healthcare landscape and improve patient outcomes across the nation.”

Viz.ai’s commitment to leveraging AI for the betterment of healthcare is a promising development in an industry constantly seeking ways to improve efficiency and patient care. As the company continues to grow and innovate, its impact on the future of medicine is sure to be significant.

Viz.ai: Revolutionizing Stroke Care with AI

AI-Powered Stroke Detection and treatment: A Game Changer

In a recent interview, Dr. Chris Mansi, CEO and co-founder of Viz.ai, shed light on the company’s remarkable journey in transforming stroke care through artificial intelligence (AI). Viz.ai, a leading AI healthcare startup, has experienced explosive growth, expanding its reach to over 1,700 hospitals and impacting patient care considerably.

Explosive Growth and Impact

Viz.ai’s success can be attributed to its groundbreaking viz.ai One™ enterprise platform, which boasts over 48 clinical AI modules. This platform leverages AI algorithms to analyze medical images, such as CT scans and MRIs, enabling rapid identification of potential stroke cases.

This AI-powered technology has streamlined diagnosis and treatment across hospitals in the United States and Europe. Dr. Mansi highlighted that the platform has been adopted by the majority of the 50 largest healthcare systems in the U.S., reaffirming Viz.ai’s position as a leading and trusted AI-powered platform.

Real-World Evidence: Saving Lives and Improving Outcomes

New studies presented at the International Stroke Conference (ISC) 2024 showcased the tangible benefits of Viz.ai’s technology. Six studies demonstrated positive outcomes associated with Viz.ai’s platform across various stroke types, including:

• Acute ischemic stroke
• Cryptogenic stroke
• Unruptured incidental cerebral aneurysms
• Brain hemorrhage

“These studies provide compelling evidence that Viz.ai’s AI-powered solutions are not only innovative but also deliver tangible benefits for patients,” Dr. Mansi stated. “We are committed to leveraging the power of AI to improve stroke care and ultimately save lives.”

Streamlining Care and Empowering Clinicians

Dr.Smith, a neurologist at a leading academic medical center, emphasized the impact of Viz.ai One™. “Time is brain when it comes to stroke,” Dr. Smith said. “Viz.ai One™ has become an invaluable tool in our arsenal, allowing us to identify and treat patients faster than ever before.”

Aside from identifying strokes, Viz.ai One™ empowers clinicians by providing:

• Complete patient facts
• Treatment recommendations
• optimization of care pathways

Looking Ahead: A Future Driven by AI Innovation

Viz.ai’s success has been widely recognized, with accolades including:

• Fast Company’s 50 most Innovative Companies
• Prix Galien Award for Best Digital Health Solution
• Second Edison Award for Viz Pulmonary Embolism
• Dr. Mansi featured as one of TIME Magazine’s 100 most influential people in AI

As AI continues to evolve, Viz.ai remains at the forefront, leading the way for a future where stroke care is faster, more accurate, and ultimately more effective.